Atherosclerosis

• FDA approval · 2022-11-29
  FDA Approved: NIACIN — Supplemental Application (Aurobindo Pharma Limited)

  FDA approves a supplemental ANDA for NIACIN (nicotinic acid) from Aurobindo Pharma Limited, authorizing the marketing of a generic NIACIN pr…

• FDA approval · 2020-10-23
  FDA Approved: EZETIMIBE — Original Application (ScieGen Pharmaceuticals Inc)

  FDA approved ScieGen Pharmaceuticals' original (ANDA) application for ezetimibe as a generic cholesterol-lowering medication.

• FDA approval · 2010-05-18
  FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)

  FDA approved Dr. Reddy's Laboratories Limited's supplemental application for clopidogrel bisulfate, a generic version of clopidogrel. The ap…